These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 18182685)

  • 41. Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
    Kanehira T; van Kranen S; Jansen T; Hamming-Vrieze O; Al-Mamgani A; Sonke JJ
    Radiother Oncol; 2021 Nov; 164():209-215. PubMed ID: 34619234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.
    Lee TF; Yeh SA; Chao PJ; Chang L; Chiu CL; Ting HM; Wang HY; Huang YJ
    Radiat Oncol; 2015 Sep; 10():194. PubMed ID: 26377924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normal tissue complication probability models for severe acute radiological lung injury after radiotherapy for lung cancer.
    Avanzo M; Trovo M; Furlan C; Barresi L; Linda A; Stancanello J; Andreon L; Minatel E; Bazzocchi M; Trovo MG; Capra E
    Phys Med; 2015 Feb; 31(1):1-8. PubMed ID: 25455442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.
    Wang D; Yin Y; Zhou Q; Li Z; Ma X; Yin Y; Li B; Bai T; Li D; Zhu J
    Med Phys; 2022 Jan; 49(1):756-767. PubMed ID: 34800297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SORS: a new software for the simulation of radiotherapy schedule.
    Tamborra P; Simeone G; Carioggia E
    Med Dosim; 2010; 35(3):208-13. PubMed ID: 19931032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. General properties of different models used to predict normal tissue complications due to radiation.
    Kuperman VY
    Med Phys; 2008 Nov; 35(11):4831-6. PubMed ID: 19070216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of different dose calculation algorithms on the estimate of NTCP for lung complications.
    Hedin E; Bäck A
    J Appl Clin Med Phys; 2013 Sep; 14(5):127-39. PubMed ID: 24036865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models.
    Bovi J; Qi XS; White J; Li XA
    Radiother Oncol; 2007 Sep; 84(3):226-32. PubMed ID: 17692980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BIOPLAN: software for the biological evaluation of. Radiotherapy treatment plans.
    Sanchez-Nieto B; Nahum AE
    Med Dosim; 2000; 25(2):71-6. PubMed ID: 10856684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of MLC leaf width and PTV margin on the treatment planning of intensity-modulated stereotactic radiosurgery (IMSRS) or radiotherapy (IMSRT).
    Chang J; Yenice KM; Jiang K; Hunt M; Narayana A
    Med Dosim; 2009; 34(2):110-6. PubMed ID: 19410139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of normal tissue complication probability of the lung using a reliability model.
    Vågane R; Olsen DR
    Acta Oncol; 2006; 45(5):610-7. PubMed ID: 16864177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical validation of the LKB model and parameter sets for predicting radiation-induced pneumonitis from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Theodorou K; Rajala J; Pitkänen MA; Holli K; Ojala AT; Hyödynmaa S; Järvenpää R; Lind BK; Kappas C
    Phys Med Biol; 2006 Feb; 51(3):L1-9. PubMed ID: 16424572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complication probability model for subcutaneous fibrosis based on published data of partial and whole breast irradiation.
    Avanzo M; Stancanello J; Trovò M; Jena R; Roncadin M; Trovò MG; Capra E
    Phys Med; 2012 Oct; 28(4):296-306. PubMed ID: 22119271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the parameters involved in the plan optimization based on the generalized equivalent uniform dose and radiobiological implications.
    Widesott L; Strigari L; Pressello MC; Benassi M; Landoni V
    Phys Med Biol; 2008 Mar; 53(6):1665-75. PubMed ID: 18367795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis.
    Kwa SL; Theuws JC; Wagenaar A; Damen EM; Boersma LJ; Baas P; Muller SH; Lebesque JV
    Radiother Oncol; 1998 Jul; 48(1):61-9. PubMed ID: 9756173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
    Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
    Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.